IRIS
ARBITRIO, Mariamena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.298
AS - Asia 1.006
EU - Europa 762
SA - Sud America 172
AF - Africa 47
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 3.297
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.240
IT - Italia 403
SG - Singapore 372
CN - Cina 162
BR - Brasile 128
IN - India 115
GB - Regno Unito 90
DE - Germania 89
VN - Vietnam 77
HK - Hong Kong 54
BD - Bangladesh 43
FI - Finlandia 37
CA - Canada 36
ID - Indonesia 27
PK - Pakistan 26
SE - Svezia 24
JO - Giordania 23
NL - Olanda 20
SA - Arabia Saudita 18
MX - Messico 16
FR - Francia 14
ES - Italia 13
IQ - Iraq 12
RU - Federazione Russa 12
ZA - Sudafrica 11
CO - Colombia 10
EG - Egitto 10
TR - Turchia 10
UA - Ucraina 10
CZ - Repubblica Ceca 9
MY - Malesia 8
EC - Ecuador 7
IE - Irlanda 7
IR - Iran 7
JP - Giappone 7
LT - Lituania 7
NG - Nigeria 7
PE - Perù 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AR - Argentina 6
AU - Australia 6
KE - Kenya 6
KR - Corea 6
ET - Etiopia 5
LB - Libano 5
MA - Marocco 5
RO - Romania 5
UZ - Uzbekistan 5
VE - Venezuela 5
CY - Cipro 4
EU - Europa 4
PH - Filippine 4
BG - Bulgaria 3
CL - Cile 3
HR - Croazia 3
PS - Palestinian Territory 3
PY - Paraguay 3
CH - Svizzera 2
GT - Guatemala 2
HN - Honduras 2
LK - Sri Lanka 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BO - Bolivia 1
CM - Camerun 1
GE - Georgia 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MD - Moldavia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
Totale 3.297
Salva come PNG Salva come JPEG
Città #
San Jose 245
Singapore 179
Ashburn 144
Chandler 124
Dallas 64
Munich 62
Santa Clara 59
Chicago 49
Bengaluru 46
Hefei 46
London 45
Hong Kong 43
Ho Chi Minh City 36
Beijing 35
Milan 29
Catanzaro 26
Turku 25
Lawrence 24
Princeton 24
New York 23
Naples 21
Los Angeles 19
Amman 15
Jeddah 13
São Paulo 13
The Dalles 13
Boardman 12
Carbonia 12
Helsinki 12
Parma 12
Montreal 11
Chennai 10
Hanoi 10
Ottawa 10
Rome 10
San Nicola Manfredi 10
Spezzano della Sila 10
Wilmington 10
Atlanta 9
Bologna 8
Delhi 8
Irbid 8
Madrid 8
Brooklyn 7
Frankfurt am Main 7
Kaunas 7
San Francisco 7
Santo Stefano di Rogliano 7
Buffalo 6
Cosenza 6
Da Nang 6
Ercolano 6
Seattle 6
Stockholm 6
Afragola 5
Cardiff 5
Des Moines 5
Dhaka 5
Hyderabad 5
Kuala Lumpur 5
Kyiv 5
Lucknow 5
Nairobi 5
Olomouc 5
Pune 5
Redmond 5
Riyadh 5
Sacramento 5
Tashkent 5
Tokyo 5
Addis Ababa 4
Ankara 4
Brescia 4
Catania 4
Charlotte 4
Dublin 4
Florianópolis 4
Islamabad 4
Johannesburg 4
Lahore 4
Manchester 4
Marano Marchesato 4
Messina 4
Mexico City 4
Nicosia 4
Paris 4
Redwood City 4
Richmond 4
Tanta 4
Thái Bình 4
Tubarão 4
West Jordan 4
Acquaviva delle Fonti 3
Ajman 3
Banyumas 3
Belo Horizonte 3
Berlin 3
Biên Hòa 3
Bristol 3
Brookline 3
Totale 1.855
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 487
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 143
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 117
miR-22 suppresses DNA ligase III addiction in multiple myeloma 103
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 100
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 94
DMET-Analyzer: automatic analysis of Affymetrix DMET Data 80
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 78
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 76
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 75
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 75
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 75
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 75
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 73
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 73
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 71
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 70
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 68
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling 67
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 66
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 64
Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: relevance to Parkinson’s disease 61
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 61
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 59
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 59
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 58
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 58
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 57
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 56
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 55
Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis 53
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 53
Integration of DNA Microarray with Clinical and Genomic Data 52
Mmrf-commpass data integration and analysis for identifying prognostic markers 51
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 51
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 51
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 50
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity 48
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 48
Ethical Perspectives on Pharmacogenomic Profiling 47
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 46
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity 43
Development and validation of bioanalytical methods for LNA-i-miR-221 quantification in human plasma and urine by LC-MS/MS 39
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 32
null 31
Polymorphisms and Pharmacogenomics of NQO2: The Past and the Future 26
Upregulation of ACHE and BACE2 genes by oleacein in Alzheimer's disease and neuroblastoma 18
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 13
null 2
Totale 3.408
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.489
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.489
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022128 2 0 0 22 5 2 10 22 30 17 13 5
2022/2023376 54 28 29 10 42 30 5 28 40 42 47 21
2023/2024469 87 34 42 37 41 70 27 38 10 17 32 34
2024/2025843 74 20 28 42 51 109 51 53 51 22 149 193
2025/20261.497 102 147 128 164 148 76 202 83 160 137 97 53
Totale 3.408